Exelixis, Inc. (EXEL) Financials

EXEL Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 2.6 billion 657.8 million
Dec. 31, 2025 2.8 billion 683.1 million
Sept. 30, 2025 2.8 billion 662.8 million
June 30, 2025 2.7 billion 644.5 million

EXEL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 249.8 million 29.1 million
Dec. 31, 2025 332.4 million 20.1 million
Sept. 30, 2025 288.8 million 30.9 million
June 30, 2025 45.4 million 36.1 million

EXEL Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 210.5 million
Dec. 31, 2025 244.5 million
Sept. 30, 2025 193.6 million
June 30, 2025 184.8 million

EXEL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 777.2 million - 169.5 million
Dec. 31, 2025 1.1 billion - 173.0 million
Sept. 30, 2025 988.5 million - 176.5 million
June 30, 2025 791.1 million - 179.8 million

EXEL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 267.3 million
Dec. 31, 2025 281.9 million
Sept. 30, 2025 278.5 million
June 30, 2025 284.4 million

EXEL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2.0 million 199.9 million 139.6 million -
Dec. 31, 2025 1.2 million 213.2 million 123.0 million 51.7 million
Sept. 30, 2025 1.5 million 199.2 million 123.7 million -
June 30, 2025 3.6 million 200.4 million 134.9 million -

EXEL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 610.8 million 20.0 million
Dec. 31, 2025 598.7 million 26.5 million
Sept. 30, 2025 597.8 million 18.6 million
June 30, 2025 568.3 million 19.5 million

EXEL Revenue by Segment
Graph available only for paid members. Upgrade to see it.

EXEL

Price: $55.37

52 week price:
33.76
57.10

Earnings Per Share: 3.02 USD

P/E Ratio: 16.46

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 986798

Ebitda: 84.9 million

Market Capitalization: 14.0 billion

Links: